We are live on ! Find out more
SCS

Syquant Capital SAS Portfolio holdings

AUM $447M
1-Year Est. Return 13.04%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$348M
AUM Growth
+$46.8M
Cap. Flow
+$24M
Cap. Flow %
6.88%
Top 10 Hldgs %
98.74%
Holding
27
New
13
Increased
1
Reduced
–
Closed
10

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$126M
2
K
Kellanova
K
+$29.4M
3
ETNB
89bio
ETNB
+$26.4M
4
IPG
Interpublic Group of Companies
IPG
+$22M
5
INFA
Informatica
INFA
+$13.3M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$103M
2
ESGR
Enstar Group
ESGR
+$24.2M
3
WBA
Walgreens Boots Alliance
WBA
+$14.7M
4
TGI
Triumph Group
TGI
+$14.6M
5
JNPR
Juniper Networks
JNPR
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.26%
2 Consumer Staples 35.62%
3 Communication Services 6.84%
4 Technology 4.9%
5 Financials 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CON
26
Concentra Group Holdings
CON
$4.04B
– –
-67,800
Closed -$1.4M
1
2

Similar funds

PT
Plimoth Trust Plymouth, Massachusetts $447M AUM 24.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $448M AUM 21.79% 1-Year Est. Return
PC
Peavine Capital Reno, Nevada $446M AUM 7.66% 1-Year Est. Return
AIS
American Investment Services Great Barrington, Massachusetts $448M AUM 21.7% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $446M AUM 13.55% 1-Year Est. Return
FTA
Financial & Tax Architects St Louis, Missouri $448M AUM 13.98% 1-Year Est. Return
GC
Guidance Capital Lousville, Kentucky $446M AUM 19.83% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return

Syquant Capital SAS's Q3 2025 Portfolio in Review

As of Q3 2025, Syquant Capital SAS held 27 positions worth $348M, up 16% from $302M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Syquant Capital SAS deployed $24M of net new capital in Q3 2025, opening 13 new positions and adding to 1 existing holding. Its largest new stake was Verona Pharma: 1,208,312 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the most notable exit was Blueprint Medicines, an estimated $103M sold.

  • Syquant Capital SAS's largest Q3 2025 buy was Verona Pharma: 1,208,312 shares worth $129M.
  • Syquant Capital SAS added most to Kellanova in Q3 2025, an estimated $29.4M increase.
  • Syquant Capital SAS fully exited Blueprint Medicines in Q3 2025, selling an estimated $103M.
  • Syquant Capital SAS's ten largest holdings make up 99% of its $348M portfolio in Q3 2025.
  • Syquant Capital SAS opened 13 new positions and closed 10 in Q3 2025.
  • Syquant Capital SAS's portfolio value rose 16% quarter-over-quarter to $348M.

Based on Syquant Capital SAS's 13F filing for Q3 2025, filed 28 Oct 2025.